General Atlantic Portfolio

Our portfolio companies are already on a strong growth trajectory — our goal is to enhance it. We have a solid track record of delivering strategic, practical and impactful support to our portfolio companies.

KGBio ×

Kalbe Genexine Biologics (“KGBio”) is an Indonesia-based joint venture between Kalbe Farma and Genexine. KGBio focuses on the in-licensing, clinical development, and manufacturing of biological products, especially in the area of immuno-oncology.

  • Sector: Life Sciences
  • Headquarters: Jakarta, Indonesia
  • Date Invested: 01/26/2021
  • Visit Website